Three waves changes, new variant strains, and vaccination effect against COVID-19 pandemic

RM El-Shabasy, MA Nayel, MM Taher… - International Journal of …, 2022 - Elsevier
It has been more than one year since the first case of the coronaviruses was infected by
COVID-19 in China. The world witnessed three waves of the corona virus till now, and more …

COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup

MK Nadim, LG Forni, RL Mehta, MJ Connor Jr… - Nature reviews …, 2020 - nature.com
Kidney involvement in patients with coronavirus disease 2019 (COVID-19) is common, and
can range from the presence of proteinuria and haematuria to acute kidney injury (AKI) …

A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models

F Ren, A Aliper, J Chen, H Zhao, S Rao, C Kuppe… - Nature …, 2024 - nature.com
Idiopathic pulmonary fibrosis (IPF) is an aggressive interstitial lung disease with a high
mortality rate. Putative drug targets in IPF have failed to translate into effective therapies at …

3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study

X Wu, X Liu, Y Zhou, H Yu, R Li, Q Zhan… - The Lancet …, 2021 - thelancet.com
Background The consequences of COVID-19 in those who recover from acute infection
requiring hospitalisation have yet to be clearly defined. We aimed to describe the temporal …

COVID-19 transmission, current treatment, and future therapeutic strategies

VS Salian, JA Wright, PT Vedell, S Nair… - Molecular …, 2021 - ACS Publications
At the stroke of the New Year 2020, COVID-19, a zoonotic disease that would turn into a
global pandemic, was identified in the Chinese city of Wuhan. Although unique in its …

COVID-19: from an acute to chronic disease? Potential long-term health consequences

V Higgins, D Sohaei, EP Diamandis… - Critical reviews in …, 2021 - Taylor & Francis
Abstract Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2). Despite pulmonary impairments being the most …

CT of post-acute lung complications of COVID-19

JJ Solomon, B Heyman, JP Ko, R Condos, DA Lynch - Radiology, 2021 - pubs.rsna.org
The acute course of COVID-19 is variable and ranges from asymptomatic infection to
fulminant respiratory failure. Patients recovering from COVID-19 can have persistent …

[HTML][HTML] Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome

LB Afrin, LB Weinstock, GJ Molderings - International journal of infectious …, 2020 - Elsevier
Abstract Objectives One-fifth of Covid-19 patients suffer a severe course of Covid-19
infection; however, the specific causes remain unclear. Mast cells (MCs) are activated by …

Benefits of pulmonary rehabilitation in COVID-19: a prospective observational cohort study

R Gloeckl, D Leitl, I Jarosch, T Schneeberger… - ERJ open …, 2021 - Eur Respiratory Soc
Background Coronavirus disease 2019 (COVID-19) can result in a large variety of chronic
health issues such as impaired lung function, reduced exercise performance and diminished …

Healing after COVID-19: are survivors at risk for pulmonary fibrosis?

LT McDonald - … Journal of Physiology-Lung Cellular and …, 2021 - journals.physiology.org
The novel SARS-CoV-2 coronavirus, which is responsible for COVID-19 disease, was first
reported in Wuhan, China, in December of 2019. The virus rapidly spread, and the World …